Company led drug alert – Iohexol 350mg/ml and 300 mg I/ml solution for injection (CLDA (20)A/01)

As a precautionary measure, Glenmark Pharmaceuticals is recalling certain lots to wholesaler and pharmacy level due to an out of specification result from the ongoing stability studies (up to 4% over the upper specifications limits for content).


Medicines and Healthcare products Regulatory Agency